Market Value279,810,276
Total Holdings37
File Date2025-02-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
SLNO / Soleno Therapeutics, Inc.
MREO / Mereo BioPharma Group plc - Depositary Receipt (Common Stock)
XENE / Xenon Pharmaceuticals Inc.
JANX / Janux Therapeutics, Inc.
TGTX / TG Therapeutics, Inc.
ALNY / Alnylam Pharmaceuticals, Inc.
MRUS / Merus N.V.
XBI / SPDR Series Trust - SPDR S&P Biotech ETF Put
ELVN / Enliven Therapeutics, Inc.
NVO / Novo Nordisk A/S - Depositary Receipt (Common Stock)
NVO / Novo Nordisk A/S - Depositary Receipt (Common Stock) Call
NVO / Novo Nordisk A/S - Depositary Receipt (Common Stock) Put
EYPT / EyePoint Pharmaceuticals, Inc.
NBIX / Neurocrine Biosciences, Inc.
CNTA / Centessa Pharmaceuticals plc - Depositary Receipt (Common Stock)
SLRN / Acelyrin, Inc.
ALEC / Alector, Inc.
IONS / Ionis Pharmaceuticals, Inc.
KURA / Kura Oncology, Inc.
SNDX / Syndax Pharmaceuticals, Inc.
CLDX / Celldex Therapeutics, Inc.
IRON / Disc Medicine, Inc.
MDGL / Madrigal Pharmaceuticals, Inc.
CRBP / Corbus Pharmaceuticals Holdings, Inc.
KROS / Keros Therapeutics, Inc.
SLN / Silence Therapeutics plc - Depositary Receipt (Common Stock)
INSM / Insmed Incorporated
RVMD / Revolution Medicines, Inc.
CRL / Charles River Laboratories International, Inc.
ANNX / Annexon, Inc.
EWTX / Edgewise Therapeutics, Inc. Put
VRDN / Viridian Therapeutics, Inc.
CRNX / Crinetics Pharmaceuticals, Inc.
SWTX / SpringWorks Therapeutics, Inc.
IDYA / IDEAYA Biosciences, Inc.
LLY / Eli Lilly and Company
LLY / Eli Lilly and Company Put
PTGX / Protagonist Therapeutics, Inc.
TARS / Tarsus Pharmaceuticals, Inc.
LRMR / Larimar Therapeutics, Inc.
VRNA / Verona Pharma plc - Depositary Receipt (Common Stock)
ARGX / argenx SE - Depositary Receipt (Common Stock)
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
NAMS / NewAmsterdam Pharma Company N.V.
AZN / AstraZeneca PLC - Depositary Receipt (Common Stock)
VRTX / Vertex Pharmaceuticals Incorporated
QTTB / Q32 Bio Inc.
DYN / Dyne Therapeutics, Inc.
SMMT / Summit Therapeutics Inc.
AXSM / Axsome Therapeutics, Inc.
ACLX / Arcellx, Inc.
RYTM / Rhythm Pharmaceuticals, Inc.
VKTX / Viking Therapeutics, Inc.
NUVL / Nuvalent, Inc.
ITCI / Intra-Cellular Therapies, Inc.
PCVX / Vaxcyte, Inc.
TECX / Tectonic Therapeutic, Inc.